IntraSight
Interventional applications platform
Workspaces and systems
  • IntraSight interventional applications platform
  • IntraSight interventional applications platform is available in different configurations, allowing for the customization that meets your lab’s needs.
  • Customer video
  • Our broad portfolio of coronary and peripheral devices includes high-resolution rotational IVUS and plug-and-play digital IVUS. IVUS helps assess the disease, guide treatment decisions and confirm therapy results.
  • Uniting today’s best-in-class imaging, physiology, and co-registration* tools on a secure applications-based platform ready for tomorrow’s innovations.
  • Optimizing lab performance with tableside touchscreen control, systems integration, data management and remote service diagnostics.
  • Delivering an outstanding user experience with a modern, intuitive interface that minimizes learning curves and increases workflow confidence.
  • Clinically proven, evidence-based iFR and FFR modalities enable quick assessment of ischemia and help determine which lesions to treat.¹,² iFR pullback technology makes it easier to assess physiology before, during, and after your procedure.
  • iFR Co-registration merges the pressure wire pullback data with the angiogram to easily identify focal and diffuse disease. IVUS Co-registration maps the 3D vessel anatomy to the angiogram to understand precisely where the disease begins and ends.
  • Standard product photograph

IntraSight

Interventional applications platform
Workspaces and systems
The IntraSight Interventional Applications Workspace is where imaging, physiology, co-registration* and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans. IntraSight is built on a new foundational platform designed to meet the evolving needs of your lab today and tomorrow.

Features
Quickly determine procedural objectives
With iFR and IVUS tri-registration* you can easily retrieve length measurements from combined IVUS, iFR and angiogram information to help determine the appropriate treatment strategy.
Quickly determine procedural objectives
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters - like luminal cross-sectional measurements - and helps aid in disease diagnosis. 74% of treatment strategies changed after IVUS was used.³
IVUS helps with disease assessment
Go beyond the angiogram
Go beyond the angiogram to further understand patient anatomy and disease. Map the 3D vessel anatomy to the angiogram to understand precisely where the disease begins and ends with IVUS Co-registration.*
Go beyond the angiogram
Specifications
  • Power requirements
    System input
    100, 120v, 220, 240VAC, 50/60Hz, 1000Va
    Monitor
    100V – 240V 50/60Hz, 39W
    Workstation
    100 – 240V, 50/60Hz, 825VA
  • Dimensions
    Workstation
    H=17", W=10", D=16.5"
    Monitor
    H=15"-19", W=15.8", D=9.7"
    Control pad (optional)
    H=2.75"-19", W=10.5", D=8.3"
    Connection box
    H=9.95", W=2.95",D=7.75"
    Touch screen module with articulating tableside mount
    H=7”, W=11.9”, D=9” Arm extends to a depth of 16.5” / 20” above the bedrail
    Control room controller
    H=5", W=15", D=10"
  • Processing and data storage
    Processor
    1 CPU with 2.3GHz (Max turbo freq. of 3.2GHz) 12 core total, 2400 MHz BUS
    Hard drive capacity
    1TB SSD SATA
    DICOM services supported
    DICOM worklist management, DICOM store
    Memory
    32GB SD RAM
    Digital archiving capacity
    Local, DVD, DICOM Network (including Worklist management, DICOM Store)
  • Ordering Information
    IntraSight 7 configuration
    IntraSight07
    IntraSight 5 configuration
    IntraSight05

Documentation

IntraSight brochure
PDF|3.65 MB

Related products

  • SyncVision Precision guidance system
    SyncVision
    The SyncVision precision guidance system is suitable with IntraSight and Core Integrated interventional platforms and streamlines lesion assessment, simplifies vessel sizing and enables precise therapy delivery all while integrating seamlessly in daily workflows in interventional suites of choice.
  • Eagle Eye Platinum Digital IVUS catheter
    Eagle Eye Platinum
    The Eagle Eye Platinum digital IVUS catheter is the #1 choice of physicians for intravascular imaging (in the US).* As a unique plug-and-play intravascular imaging catheter it is designed for ease of use and deliverability. Features include a soft tapered tip, GlyDx hydrophilic coating for increased lubricity, a long, rapid exchange lumen for improved pushability, three radiopaque markers, and compatibility with SyncVision for co-registration with angiography.
  • Eagle Eye Platinum ST Digital IVUS short tip catheter
    Eagle Eye Platinum ST
    The Eagle Eye Platinum ST digital IVUS catheter offers a 2.5 mm tip-to-imaging distance designed to assess more of the vessel than standard catheters by providing a closer visualization of highly stenosed lesions and distal anatomy. The short tip catheter fits through all 5F guides and has all features of our top-selling Eagle Eye Platinum model, including plug-and-play simplicity, three radiopaque markers, GlyDx hydrophilic coating, and SyncVision compatibility.*
  • Verrata Plus Pressure guide wire
    Verrata Plus
    For over 20 years Philips has led the way in physiology, putting patients first through continuous innovation. Experience our 10ᵗʰ generation physiology wire: Verrata Plus.
Disclaimer
1. Davies JE, et al., Use of the Instantaneous Wave-free Ration or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
2. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
3. Witzen B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470.
* Co-registration tools available within IntraSight 7 configuration via SyncVision
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device
Philips reserves the right to change product specifications without prior notification.
©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners.